Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells (Q44810530)

6 December 2017

title

Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells (English)

1 reference

Duchenne muscular dystrophy

6 December 2017

main subject

1 reference

5

Jean-Pierre Bouchard

0 references

author name string

Daniel Skuk

1

1 reference

6 December 2017

Brigitte Roy

2

1 reference

6 December 2017

Marlyne Goulet

3

1 reference

6 December 2017

Pierre Chapdelaine

4

1 reference

6 December 2017

Raynald Roy

6

1 reference

6 December 2017

Francine J Dugré

7

1 reference

6 December 2017

Jean-Guy Lachance

8

1 reference

6 December 2017

Louise Deschênes

9

1 reference

6 December 2017

Senay Hélène

10

1 reference

6 December 2017

Michel Sylvain

11

1 reference

6 December 2017

Jacques P Tremblay

12

1 reference

6 December 2017

publication date

1 March 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

9

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

475-482

1 reference

Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Experimental and therapeutic approaches to muscular dystrophies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Myoblast transfer in Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Myoblast transplantation in whole muscle of nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Human myoblast transplantation: preliminary results of 4 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Very efficient myoblast allotransplantation in mice under FK506 immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Myoblast transplantation in monkeys: control of immune response by FK506

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Direct effects of cyclosporin A and cyclophosphamide on differentiation of normal human myoblasts in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Cyclophosphamide immunosuppression does not permit successful myoblast allotransplantation in mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Cough in tetraplegic subjects: an active process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Resetting the Problem of Cell Death Following Muscle-Derived Cell Transplantation: Detection, Dynamics and Mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Dynamics of the early immune cellular reactions after myogenic cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Retention of differentiation potentialities during prolonged cultivation of myogenic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Transplantation of Human Myoblasts in SCID Mice as a Potential Muscular Model for Myotonic Dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

Human myoblast transplantation: A simple assay for tumorigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.11.023

10.1016/J.YMTHE.2003.11.023

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference